Clinical Trial Update: A Randomized, Double-Blind, Single-Center Clinical Study on the Efficacy of Naltrexone Implant in Antagonizing Opioid Agonist Hydromorphone [Phase 2]

View source ↗

Summary

Phase 2 randomized, double-blind study evaluating the efficacy of a naltrexone implant to antagonize the opioid agonist hydromorphone in opioid dependence; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence

Drugs mentioned

• Hydromorphone (hydromorphone)
• Naltrexone implant (naltrexone implant)

Snippet

Sponsor: Shenzhen Sciencare Medical Industries Co., Ltd. | Conditions: Opioid Dependence | Phase 2 | Status: COMPLETED